Glanbia Full Year 2025 Results

Summary by AI BETAClose X

Glanbia plc reported full-year 2025 results with revenue increasing 2.3% to $3.9 billion, though EBITDA declined 9.4% to $499.1 million, primarily due to record whey input costs impacting Performance Nutrition. Adjusted EPS decreased by 3.4% to 134.93 $cent, while basic EPS rose 19.7% to 73.16 $cent. The company recommended a final dividend of 25.67 €cent per share, a 10% increase, and returned approximately €197 million to shareholders through share buybacks, with a further €100 million authorized for 2026. Strategic updates included the sale of SlimFast and Body & Fit, and acquisitions in Health & Nutrition, with a group-wide transformation program targeting $60 million in annual cost savings by 2027. Glanbia anticipates 7% to 11% adjusted EPS growth in constant currency for 2026.

Disclaimer*

UK 100

Latest directors dealings